Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent

Journal of Invasive Cardiology

Volumn 20, Issue 8, 2008, Pages 423-425

  Zhang, Feng ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Drug eluting stent; Incomplete stent apposition; Restenosis; Thrombosis; Zotarolimus

Indexed keywords

ACETYLSALICYLIC ACID; PACLITAXEL; PHOSPHORYLCHOLINE; ZOTAROLIMUS;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; DRUG ELUTING STENT; ECG ABNORMALITY; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LATE INCOMPLETE STENT APPOSITION; MALE; PERCUTANEOUS CORONARY INTERVENTION; Q WAVE; ST SEGMENT ELEVATION; THROMBUS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; REOPERATION; SIROLIMUS; THROMBOSIS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 48749100649     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Serruys PW, Degertekin M, Tanabe K, et al; for the RAVEL Study Group. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
2. Colombo A, Drzewiecki J, Banning A, et al for the TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderaterelease polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-794.
3. Moses JW, Leon MB, Popma JJ, et al for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
4. Sakamoto H, Ishikawa T, Mutoh M, et al. Effectiveness of a Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis Inside a Bare Metal Stent. Int Heart J 2006;47:651-661.
5. Zhang F, Ge J, Qian J, et al. Sirolimus-eluting stents in real-World Patients with ST-Segment Elevation Acute Myocardial Infarction. Int Heart J 2007;48:303-311.
6. Bavry AA, Kumbhani DJ, Helton TJ, et al. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061.
7. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007 Mar 8;356:998-1008.
8. Zhang F, Qian JY, Ge JB. Very late stent thrombosis in late stent malapposition after sirolimus-eluting stent implantation. Int Heart J 2007;48:591-596.
9. Qian JY, Zhang F, Fan B, et al. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation. Chin Med J (Engl) 2008;121:498-502.
10. Meredith IT, Ormiston J, Whitbourn R, et al. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. EuroInterv 2005;1:157-164.
11. Fajadet J, Wijns W, Laarman GJ, et al for the ENDEAVOR II Investigators. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Minerva Cardioangiol 2007;55:1-18.
12. Kandzari DE, Leon MB, Popma JJ, et al for the ENDEAVOR III Investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 2006;48:2440-2447.
13. Zhang F, Qian JY, Ge JB. Late stent malapposition and marked positive vessel remodeling after sirolimus-eluting coronary stent implantation. Chin Med J (Engl) 2006;119:349-350.
14. Zhang F, Qian JY, Ge JB. Rapid development of late stent malappositon and coronary aneurysm following implantation of a paclitaxel-eluting coronary stent. Chin Med J (Engl) 2007;120:614-616.
15. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: A serial intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:1002-1005.
16. Yang J, Wang N, Zhang X, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006;47:707-713.
17. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-419.
18. Katayama T, Yamamoto T, Iwasaki Y, Yano K. Two cases of very late stent thrombosis after implantation of a sirolimus-eluting stent presenting as AMI. Int Heart J 2007;48:393-397.
19. Qian J, Zhang F, Wu H, et al. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent Implantation. Int J Cardiovasc Imaging 2008;24:133-139.
20. Lemos PA, Saia F, Ligthart JM, et al. Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003;108:257-260.
21. Lemos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004;109:1366-370.
22. Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 2006;113:2293-2300.
23. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434.
24. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.